VanEck Associates’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.46M Sell
25,974
-264
-1% -$99.1K 0.01% 647
2026
Q1
$7.4M Buy
26,238
+682
+3% +$198K 0.01% 677
2025
Q4
$7.56M Buy
25,556
+4,698
+23% +$1.42M 0.01% 646
2025
Q3
$5.13M Buy
20,858
+524
+3% +$106K ﹤0.01% 758
2025
Q2
$3.19M Buy
+20,334
New +$2.16M ﹤0.01% 874
2025
Q1
Sell
-99,684
Closed -$9.19M 1393
2024
Q4
$9.19M Buy
99,684
+32,418
+48% +$2.54M 0.01% 491
2024
Q3
$3.87M Buy
67,266
+19,221
+40% +$993K ﹤0.01% 733
2024
Q2
$2.75M Buy
+48,045
New +$2.42M ﹤0.01% 785

Other funds holding CLS

VanEck Associates's CLS Position: Q2 2026 in Review

VanEck Associates reduced its Celestica (CLS) stake by 1% in Q2 2026, selling an estimated $99.1K and leaving 25,974 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #647.

VanEck Associates first reported a position in CLS in Q2 2024 and has held it in 8 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • VanEck Associates held 25,974 shares of Celestica worth $9.46M as of Q2 2026.
  • VanEck Associates sold 264 Celestica shares in Q2 2026, an estimated $99.1K.
  • Celestica made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #647 holding.
  • VanEck Associates first reported a position in Celestica in Q2 2024 and has held it in 8 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.